Curcumin trial reports changes in inflammation and liver measurements
In patients with diabetes and metabolic fatty liver disease, curcumin lowered an inflammation marker and liver measurements compared with placebo. The abstract gives no effect sizes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Curcumin lowered tumor necrosis factor, the primary outcome, compared with placebo at every follow-up. The abstract also reports lower liver fat and stiffness, which were secondary outcomes. These findings concern inflammation and liver measurements; they do not establish fewer clinical complications or reveal how large the differences were.
This abstract-based account lacks effect sizes and confidence intervals for the main results. Adverse-event results are also absent, limiting assessment of benefit magnitude and tolerability.
What researchers found
Tumor necrosis factor levels
Curcumin versus placebo at every follow-up during 12 months; the abstract does not quantify the difference.
Primary and secondary outcomes
The abstract identifies tumor necrosis factor as the primary outcome. Liver fat and stiffness appear among the secondary outcomes. This designation does not establish when the outcome plan was specified.
Measurements have limits
The trial reports changes in inflammatory markers, antioxidant activity and liver measurements. The abstract does not describe fewer liver-related complications, so these changes cannot be presented as demonstrated clinical protection.
The original publication
Curcumin for Inflammation Control in Individuals with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial.
Yaikwawong M, Jansarikit L, Jirawatnotai S et al.
Nutrients · 2025
- PubMed ID
- 40573083
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.